The nation of Zimbabwe has turned down a substantial American health deal valued at 367 million US dollars (272 million pounds) over five years due to the United States' request for confidential information.
This move came to light following a official document dated December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "unbalanced".
An official representative has since clarified that the United States was demanding access to genetic material for scientific study and commercial gain but was unwilling to share the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for further talks to find a agreement suitable to all parties so the country's critical HIV programme can continue.
Wider Context
Zimbabwe's decision comes after a similar situation in Kenya, where a court halted a similar health funding agreement after concerns were filed about the security of Kenyans' health data.
After resuming office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government deals to enhance openness and responsibility.
As per reports, 16 African countries have to date agreed to these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to share its biological resources and data for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our nation would supply the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our people if a new disease outbreak emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting systems already set up through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This framework is intended to guarantee that when a nation provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to further discussions with our American counterparts on how subsequent collaboration could be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Response
A leading public health body said it acknowledged the government's concerns, but urged that talks should continue considering much of the nation's Aids initiatives were funded by external financing.
"If specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.
The halted deal underscores the complex debate between accepting much-needed foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.